Patient presents with complaints consistent with macular degeneration symptoms, including blurred vision, central vision loss, scotomas, and difficulty with activities of daily living such as reading and driving.  Visual acuity assessment reveals reduced central vision in the affected eye(s).  Amsler grid testing demonstrates metamorphopsia or central scotoma.  Fundoscopic examination reveals drusen, retinal pigment epithelium (RPE) changes consistent with either dry age-related macular degeneration (AMD) or wet AMD characterized by choroidal neovascularization (CNV), subretinal fluid, andor hemorrhage.  Fluorescein angiography (FA) and optical coherence tomography (OCT) were performed to confirm diagnosis and assess the extent of macular involvement.  Differential diagnosis includes diabetic retinopathy, macular edema, and other retinal disorders.  Diagnosis of age-related macular degeneration, dry form or wet form, was established based on clinical findings and diagnostic imaging results.  Patient education provided regarding AMD progression, risk factors, and available treatment options including anti-VEGF therapy for wet AMD, low vision rehabilitation, and nutritional support with AREDS2 vitamins.  Follow-up scheduled for monitoring disease progression and management. ICD-10 code H35.3 (Age-related macular degeneration) assigned.  CPT codes for diagnostic testing, such as 92250 (ophthalmoscopy), 92275 (fluorescein angiography), and 92134 (OCT) were billed appropriately.  Patient advised to report any changes in vision promptly.